Transaction · 0001231589-26-000006

MAHON PAUL A

MAHON PAUL A, EVP, GC, reported a transaction classified as exercise at UNITED THERAPEUTICS Corp involving 8300.000000 shares for an estimated $0.00. Reported holdings after the transaction were 33500.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MEVP, GC
UTHRUNITED THERAPEUTICS Corp
Filing timeMar 05
Trade dateMar 05, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$485.06
Pre-filing
1mo ago -1.4%1w ago +3.8%1d ago +1.1%
Returns since
7d +9.8%30d +16.4%90d +13.3%180d +6.8%1y +6.8%

UTHR price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
UTHR since 2026-03-05Filed 183 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001231589-26-000006
Stock Option
Transaction date
Mar 05, 2026
Filed Mar 05, 2026, 12:00 AM · 0d delay
Shares
8.30k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
33.5k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership 10b5-1 Detected
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP & GENERAL COUNSEL

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

  2. F10

    This transaction was executed in multiple trades at prices ranging from $486.41 to $486.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  3. F11

    This transaction was executed in multiple trades at prices ranging from $487.475 to $487.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pro…

  4. F2

    Includes 63 shares of common stock acquired on March 4, 2026 under the United Therapeutics Employee Stock Purchase Plan.

  5. F3

    This transaction was executed in multiple trades at prices ranging from $478.82 to $479.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  6. F4

    This transaction was executed in multiple trades at prices ranging from $479.82 to $480.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  7. F5

    This transaction was executed in multiple trades at prices ranging from $481.02 to $481.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  8. F6

    This transaction was executed in multiple trades at prices ranging from $482.025 to $482.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pro…

  9. F7

    This transaction was executed in multiple trades at prices ranging from $483.07 to $484.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  10. F8

    This transaction was executed in multiple trades at prices ranging from $484.07 to $484.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  11. F9

    This transaction was executed in multiple trades at prices ranging from $485.10 to $485.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

Original filing · 0001231589-26-000006
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

UTHR